BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37035407)

  • 21. Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation.
    Marlu R; Malvezzi P; Seyve L; Jouve T; Maurizi J; Defendi F; Carron PL; Christophe M; Le Gouellec A; Polack B; Rostaing L
    Thromb Res; 2018 Jun; 166():113-121. PubMed ID: 29747114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
    Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
    Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double filtration plasmapheresis in antibody-incompatible kidney transplantation.
    Higgins R; Lowe D; Hathaway M; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
    Ther Apher Dial; 2010 Aug; 14(4):392-9. PubMed ID: 20649760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
    Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
    J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis.
    Kimura K; Tsuda H; Kwangseok Y; Tamura N; Kanai Y; Kobayashi S
    Ther Apher Dial; 2005 Feb; 9(1):64-8. PubMed ID: 15828909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units.
    Paglialonga F; Schmitt CP; Shroff R; Vondrak K; Aufricht C; Watson AR; Ariceta G; Fischbach M; Klaus G; Holtta T; Bakkaloglu SA; Zurowska A; Jankauskiene A; Vande Walle J; Schaefer B; Wright E; Connell R; Edefonti A
    Pediatr Nephrol; 2015 Jan; 30(1):103-11. PubMed ID: 25135618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Overlap Syndrome in Patients With Biopsy-Proven Glomerulonephritis.
    Jarrot PA; Chiche L; Hervier B; Daniel L; Vuiblet V; Bardin N; Bertin D; Terrier B; Amoura Z; Andrés E; Rondeau E; Hamidou M; Pennaforte JL; Halfon P; Daugas E; Dussol B; Puéchal X; Kaplanski G; Jourde-Chiche N
    Medicine (Baltimore); 2016 May; 95(22):e3748. PubMed ID: 27258503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation.
    Noble J; Metzger A; Naciri Bennani H; Daligault M; Masson D; Terrec F; Imerzoukene F; Bardy B; Fiard G; Marlu R; Chevallier E; Janbon B; Malvezzi P; Rostaing L; Jouve T
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33806743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of different apheresis modalities on coagulation factor XIII level during antibody removal in ABO-blood type incompatible living related renal transplantation.
    Hanafusa N; Hamasaki Y; Kawarasaki H; Kido R; Shibagaki Y; Ishikawa A; Enomoto Y; Fujita T; Noiri E; Nangaku M
    Transfus Apher Sci; 2013 Oct; 49(2):254-8. PubMed ID: 23827327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional citrate anticoagulation vs systemic heparin anticoagulation for double-filtration plasmapheresis.
    Teh SP; Ho QY; Kee YST; Thangaraju S; Tan RY; Teo SH; Tan HK; Tan CS; Choong HLL; Ng LC; Abdul Rahman M; Lim AEL; Kaushik M
    J Clin Apher; 2023 Feb; 38(1):16-23. PubMed ID: 36197100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated recovery from nephrotic syndrome with acute renal failure by double filtration plasmapheresis in a patient with lupus podocytopathy.
    Iwazu Y; Akimoto T; Izawa S; Inoue M; Muto S; Ando Y; Iwazu K; Fukushima N; Yumura W; Kusano E
    Clin Exp Nephrol; 2012 Jun; 16(3):485-9. PubMed ID: 22350466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognosis and its risk factors in ANCA-associated glomerulonephritis patients treated with initial renal replacement therapy].
    Chen YH; Liu X; Liu ZZ; Li K; Yang L; Zhang HT; Zeng CH; Xu F; Hu WX
    Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(4):274-279. PubMed ID: 29397613
    [No Abstract]   [Full Text] [Related]  

  • 33. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation.
    Sawada T; Fuchinoue S; Kawase T; Kubota K; Teraoka S
    Clin Transplant; 2004 Jun; 18(3):254-60. PubMed ID: 15142045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early and late effects of therapeutic plasma exchange in patients with systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis: A single-center experience.
    Al Hamzi HA; Al-Mayouf SM; Al Shaikh AA; Al-Sheikh HA; Alshomar AA; Al Humaidan HA; Al Dalaan AN; Al Saleh SS
    Saudi J Kidney Dis Transpl; 2019; 30(4):775-780. PubMed ID: 31464233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical analysis of single filtration plasmapheresis using continuous renal replacement therapy machines in kidney transplantation.
    Lim E; Kim Y; Jeong JC; Park I; Kim H; Lee SH; Oh CK; Shin GT
    Kidney Res Clin Pract; 2017 Jun; 36(2):192-199. PubMed ID: 28680827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fluctuation of skin perfusion pressure in hemodialysis patients treated with LDL apheresis therapy: A comparison of LDL adsorption and double filtration plasmapheresis.
    Yoshimura H; Yoshikawa Y; Noguchi Y; Totani T; Kusuta R; Shimazu K; Tanaka A; Komura K
    J Clin Apher; 2023 Aug; 38(4):362-367. PubMed ID: 36367055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of Wegener's granulomatosis with pulmonary bleeding successfully treated with double filtration plasmapheresis (DFPP).
    Iwatani H; Uzu T; Kakihara M; Nakayama Y; Kanasaki K; Yamato M; Hirai Y; Umimoto K; Yamauchi A
    Clin Exp Nephrol; 2004 Dec; 8(4):369-74. PubMed ID: 15619039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of rituximab to hepatitis C-positive, ABO-incompatible renal transplantation.
    Tsai MK; Yang CY; Wu MS; Lee PH
    Int J Artif Organs; 2009 May; 32(5):308-9. PubMed ID: 19569040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience of ABO-incompatible living kidney transplantation after double filtration plasmapheresis.
    Ishikawa A; Itoh M; Ushlyama T; Suzuki K; Fujita K
    Clin Transplant; 1998 Apr; 12(2):80-3. PubMed ID: 9575393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of double-filtration plasmapheresis on coagulation profiles and the risk of bleeding.
    Pan SY; Tao-Min Huang T; Lin YC; Liu HT; Chou SC; Lee CY; Chen CC; Fu CH; Chao CC; Wu VC
    J Formos Med Assoc; 2024 Feb; ():. PubMed ID: 38395630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.